These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design. Gross JE; Caceres S; Poch K; Epperson LE; Hasan NA; Jia F; Calado Nogueira de Moura V; Strand M; Lipner EM; Honda JR; Strong M; Davidson RM; Daley CL; Nick JA PLoS One; 2023; 18(12):e0291910. PubMed ID: 38117792 [TBL] [Abstract][Full Text] [Related]
17. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis. Moore JE; Millar BC Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands. Zomer D; van Ingen J; Hofland R; J Cyst Fibros; 2023 Mar; 22(2):327-333. PubMed ID: 36347785 [TBL] [Abstract][Full Text] [Related]
19. Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Burke A; Thomson RM; Wainwright CE; Bell SC Semin Respir Crit Care Med; 2023 Apr; 44(2):287-296. PubMed ID: 36649736 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Martiniano SL; Sontag MK; Daley CL; Nick JA; Sagel SD Ann Am Thorac Soc; 2014 Jan; 11(1):36-44. PubMed ID: 24251858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]